Kathrine Blom

Does Pharmaceutical Compounding of Vascular Endothelial Growth Factor Inhibitors for Intravitreal Use Alter the Risk of Post-injection Endophthalmitis?

M. Moe, R. Bragadóttir, M. S. Sivertsen, 2020, Ocular immunology and inflammation.

Endophthalmitis in Oslo, Norway

Ø. K. Jørstad, R. Bragadóttir, Kathrine Blom, 2019, Acta ophthalmologica.

Primary vitrectomy or intravitreal antibiotics followed by early vitrectomy for acute endophthalmitis: A prospective observational study

N. Hermansen, Ø. K. Jørstad, R. Bragadóttir, 2022, Acta ophthalmologica.

Mask use by patients in the context of COVID‐19 can increase the risk of postinjection endophthalmitis

M. Moe, Ø. K. Jørstad, R. Bragadóttir, 2021, Acta ophthalmologica.

L etter to the Editor Mask use by patients in the context of COVID-19 can increase the risk of postinjectionendophthalmitis

M. Moe, Ø. K. Jørstad, Kathrine Blom, 2021 .

Re: Writing committee for the Post-Injection Endophthalmitis Study Group, et al.: The influence of universal face mask use on endophthalmitis risk after intravitreal anti-vascular endothelial growth factor injections (Ophthalmology. 2021;128:1620-1626).

M. Moe, Ø. K. Jørstad, R. Bragadóttir, 2022, Ophthalmology.